SCHEMBL21972250

SCHEMBL21972250

CN(C)c1cc(-c2ccccc2)cc(N(C)C)c1C1N(C)c2ccccc2N1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 2/20 0.36
▸ MAPT P10636 2/20 0.31
▸ EGFR P00533 1/20 0.31
▸ CRHBP P24387 1/20 0.31
▸ CRHR2 Q13324 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ NPY1R P25929 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ PGR P06401 1/20 0.30
▸ TAAR1 Q96RJ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20739438 0.83 PDGFRB (0.57) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21971004 0.81 PDGFRB (0.53) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21972258 0.79 LMNA (0.46) PDGFRBKDM4ELMNAHTTMEN1
SCHEMBL21971408 0.72 PDGFRB (0.47) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21972251 0.72 LMNA (0.49) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21972266 0.72 LMNA (0.49) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21972255 0.72 LMNA (0.42) PDGFRBKDM4ELMNAHTTMEN1
SCHEMBL19100048 0.70 KDM4E (0.44) PDGFRBKDM4ELMNAHTTMAPK1
SCHEMBL20508364 0.70 PDGFRB (0.53) PDGFRBKDM4ELMNAHTTMAPT
SCHEMBL21970984 0.69 PDGFRB (0.56) PDGFRBKDM4ELMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 PDGFRB 2517/4885KDM4E 4526/4885LMNA 4733/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 PDGFRB 2499/4885KDM4E 4760/4885LMNA 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback